Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents

Pharmacotherapy

Volumn 26, Issue 9 I, 2006, Pages 1221-1231

  Dupuis, L Lee ^a,b,c   Taddio, Anna ^a,b,c   Kerr, Elizabeth N ^a   Kelly, Andrea ^a,c   MacKeigan, Linda ^c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antineoplastic induced nausea; Children; Nausea; Pediatric Nausea Assessment Tool; Pediatric oncology; PeNAT

Indexed keywords

ANTINEOPLASTIC AGENT; MORPHINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CHILD; CHILDHOOD CANCER; CONSTRUCT VALIDITY; CORRELATION ANALYSIS; DESCRIPTIVE RESEARCH; DIETARY INTAKE; DISCRIMINANT VALIDITY; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PARENT; PEDIATRIC HOSPITAL; PEDIATRIC NAUSEA ASSESSMENT TOOL; PILOT STUDY; PROSPECTIVE STUDY; RELIABILITY; SCORING SYSTEM; UNIVERSITY HOSPITAL; VALIDATION PROCESS; VOMITING;

ADOLESCENT; ANTIEMETICS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NAUSEA; NEOPLASMS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 33748121613     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.9.1221     Document Type: Article

References (36)

1. Coates A, Abraham S, Kaye SB, et al. On the receiving end: patients' perception of the side effects of cancer chemotherapy. Eur J Cancer Clin Oncol 1983;19:203-8.
2. Griffin AM, Butow PN, Coates AS, et al. On the receiving end. V. Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 1996;7:189-95.
3. De Boer-Dennert M, de Wit R, Schmitz PlM, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 1997;76:1055-61.
4. Del Favero A, Roila F, Basurto C, et al. Assessment of nausea. Eur J Clin Pharmacol 1990;38:115-20.
5. Rhodes VA, Watson PM, Johnson MH. Development of reliable and valid measures of nausea and vomiting. Cancer Nurs 1984;7:33-41.
6. Martin CG, Rubenstein EB, Elting LS, et al. Measuring chemotherapy-induced nausea and emesis: psychometric properties of a quality of life questionnaire. Cancer 2003;98:645-5.
7. Hesketh PJ, Gralla RJ, du Bois A, Tonato M. Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity. Support Care Cancer 1998;6:221-7.
8. Koseoglu V, Kurecki AE, Atay AA. Comparison of the efficacy and side-effect of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study. Eur J Pediatr 1998;157:806-10.
9. Dick GS, Meller ST, Pinkerton CR. Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy-induced emesis. Arch Dis Child 1995;73:243-5.
10. Alvarez O, Freeman A, Bedros A, et al. Randomized double-blind crossover ondansetron-dexamethasone versus ondansetron-placebo study for the treatment of chemotherapy-induced nausea and vomiting in pediatric patients with malignancies. J Pediatr Hematol Oncol 1995;17:145-50.
11. Zeltzer LK, LeBaron S, Zeltzer PM. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. Am J Pediatr Hematol Oncol 1984;6:5-16.
12. Zeltzer L, LeBaron S, Zeltzer PM. The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. J Clin Oncol 1984;2:683-90.
13. Phipps S, Dunavant M, Jaywardene D, Srivastiva DK. Assessment of health-related quality of life in acute in-patient settings: use of the BASES instrument in children undergoing bone marrow transplantation. Int J Cancer 1999;12(suppl): 18-24.
14. Tyc VL, Mulhern RK, Fairclough D, et al. Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings. J Dev Behav Pediatr 1993;14:236-41.
15. Scheeler NL, Berde CB, Yaster M, eds. Pain in infants, children, and adolescents. Philadelphia: Williams & Wilkins, 1993.
16. Champion GD, Goodenough B, von Baeyer CL, Thomas W. Measurement of pain by self-report. In: Finley GA, McGrath PJ, eds. Measurement of pain in infants and children. Progress in pain research and management, vol 10. Seattle, WA: IASP Press, 1998:123-60.
17. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988;14:9-17.
18. Chambers CT, Johnston C. Developmental differences in children's use of rating scales. J Pediatr Psychol 2002;27:27-36.
19. Hesketh PJ, Kris MG, Grunberg SM, et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 1997;15:103-9.
20. Cancer Therapy Evaluation Program. Common toxicity criteria, version 2.0. Bethesda, MD: National Cancer Institute, National Institutes of Health, 1998.
21. Nunnally JC. Psychometric theory, 2nd ed. New York: McGraw-Hill, Inc., 1978.
22. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use, 2nd ed. Oxford: Oxford University Press, 1995.
23. Dupuis LL, Lau R, Greenberg ML. Effectiveness of strategies for the prevention of acute antineoplastic-induced nausea and vomiting in children with acute lymphoblastic leukemia. Can J Hosp Pharm 1999;52:350-61.
24. Holdsworth MT, Raisch DW, Duncan MH, et al. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother 1995;29:16-21.
25. Kusnierczyk NM, Saunders EF, Dupuis LL. Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation. Bone Marrow Transplant 2002;30:119-24.
26. Holdsworth MT, Adams VR, Raisch DW, et al. Computerized system for outcomes-based antiemetic therapy in children. Ann Pharmacother 2000;34:1101-8.
27. Woodgate R, McClement S. Symptom distress in children with cancer: the need to adopt a meaning-centered approach. J Pediatr Oncol Nurs 1998;15:3-12.
28. Wilcock L, Dupuis LL. Preliminary evaluation of antiemetics in children undergoing bone marrow transplant conditioning [abstr]. Can J Hosp Pharm 1998;51:88.
29. Dupuis LL, Lau R, Greenberg ML. Delayed nausea and vomiting in children receiving antineoplastics. Med Pediatr Oncol 2001;37:115-21.
30. Orchard PJ, Rogosheske J, Burns L, et al. A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation. Biol Blood Marrow Transplant 1999;5:386-93.
31. Geib K, Wright F. Pediatric nausea, vomiting, and retching guide [abstr]. J Pediatr Oncol Nurs 2000;17:94.
32. Liu W, Koole WA, Crouse VL. Standardization and documentation of nausea assessment using a faces rating scale in a pediatric setting [abstr]. J Pediatr Pharm Pract 2000;5:196.
33. Zeltzer LK, LeBaron S, Richie DM, et al. Can children understand and use a rating scale to quantify somatic symptoms? Assessment of nausea and vomiting as a model. J Consult Clin Psychol 1988;56:567-72.
34. Hinds PS, Quargnenti AG, Wentz TJ. Measuring symptom distress in adolescents with cancer. J Pediatr Oncol Nurs 1992;9:84-6.
35. Scolnik D, Atkinson V, Hadi M, et al. Words used by children and their primary caregivers for private body parts and functions. Can Med Assoc J 2003;169:1275-9.
36. Del Favero A, Tonato M, Roila F. Issues in the measurement of nausea. Br J Cancer 1992;66(suppl XIX):S69-71.